Literature DB >> 8615969

The role of toluidine blue in assessing margin status after resection of squamous cell carcinomas of the upper aerodigestive tract.

L G Portugal1, K M Wilson, P W Biddinger, J L Gluckman.   

Abstract

OBJECTIVE: To determine the efficacy of toluidine blue in assessing margin status after removal of squamous cell carcinomas of the upper aerodigestive tract.
DESIGN: A prospective study of 50 consecutive patients undergoing surgical resection of squamous cell carcinomas of the upper aerodigestive tract was performed during February 1 to December 1, 1993. After tumor resection, toluidine blue was applied directly to the remaining unresected mucosa. The staining characteristics of the mucosa were then compared with those of frozen-section biopsy specimens of the margins and with the permanent histologic findings of the resected tumor specimen.
RESULTS: In three cases, toluidine blue identified a positive margin, which was confirmed on frozen and permanent section. In six cases, false-positive staining was noted, which was most frequently related to traumatic handling of the mucosa during the resection. In no case was a positive margin found on histologic staining that failed to stain with toluidine blue. During routine staining of surrounding unresected mucosa, three cases of a second primary tumor that was not seen on routine evaluation before tumor removal were identified with toluidine blue. In one case, a second T1 oral cavity lesion was found, while in the other cases, separate pharyngeal lesions were identified.
CONCLUSION: Based on these findings, it appears that toluidine blue improved the ability to assess margin status at the time of resection, and we advocate its use after resection of tumors to the upper aerodigestive tract.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615969     DOI: 10.1001/archotol.1996.01890170051010

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  9 in total

1.  Chemiluminescence and Toluidine Blue as Diagnostic Tools for Detecting Early Stages of Oral Cancer: An invivo Study.

Authors:  Neha Vashisht; A Ravikiran; Y Samatha; Purna Chandra Rao; Ravindra Naik; Divy Vashisht
Journal:  J Clin Diagn Res       Date:  2014-04-15

2.  A comparative analysis of toluidine blue with frozen section in oral squamous cell carcinoma.

Authors:  Montasir Junaid; Moaz M Choudhary; Zain A Sobani; Ghulam Murtaza; Sadaf Qadeer; Naeem S Ali; Mumtaz J Khan; Anwar Suhail
Journal:  World J Surg Oncol       Date:  2012-04-16       Impact factor: 2.754

3.  The usefulness of toluidine staining as a diagnostic tool for precancerous and cancerous oropharyngeal and oral cavity lesions.

Authors:  E Allegra; N Lombardo; L Puzzo; A Garozzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-08       Impact factor: 2.124

4.  Validity of Toluidine Blue test as a diagnostic tool for high risk oral potentially malignant disorders- a multicentre study in Sri Lanka.

Authors:  R D Jayasinghe; P V K S Hettiarachchi; Dilrukshi Amugoda; Menaka Kumaraarachchi; R L P R Liyanage; B S M S Siriwardena; Ranjith Gunasena; A H T S Karunatilake; H K Amarasinghe
Journal:  J Oral Biol Craniofac Res       Date:  2020-08-19

5.  Supravital staining: It's role in detecting early malignancies.

Authors:  Mahesh Chandra Hedge; Panduranga M Kamath; Suja Shreedharan; Naveen Kumar Dannana; Ravikumar M Raju
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2006-01

Review 6.  Oral cancer treatment.

Authors:  Terry A Day; Betsy K Davis; M Boyd Gillespie; John K Joe; Megan Kibbey; Bonnie Martin-Harris; Brad Neville; Mary S Richardson; Steven Rosenzweig; Anand K Sharma; Michelle M Smith; Stacy Stewart; Robert K Stuart
Journal:  Curr Treat Options Oncol       Date:  2003-02

7.  Early Glottic Cancer Treated by Transoral Laser Surgery Using Toluidine Blue for the Definition of the Surgical Margins: A Pilot Study.

Authors:  Eugenia Allegra; Maria Rita Bianco; Chiara Mignogna; Gaetano Davide Drago; Domenico Michele Modica; Lidia Puzzo
Journal:  Medicina (Kaunas)       Date:  2020-07-03       Impact factor: 2.430

8.  Toluidine blue versus frozen section for assessment of mucosal tumor margins in oral squamous cell carcinoma.

Authors:  Hana'a Hezam Algadi; Amany Abd-Elhameed Abou-Bakr; Omer Mohammed Jamali; Louloua Mohamed Fathy
Journal:  BMC Cancer       Date:  2020-11-25       Impact factor: 4.430

9.  Toluidine blue: A review of its chemistry and clinical utility.

Authors:  Gokul Sridharan; Akhil A Shankar
Journal:  J Oral Maxillofac Pathol       Date:  2012-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.